NASDAQ:VRDN | EBITDA | Viridian Therapeutics, Inc.\DE

Complete source-backed ebitda history.

Available history
2013-06-30 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$116.05M
2025-12-31-$122.63M
2025-03-31-$93.75M
2024-12-31-$87.35M
2024-03-31-$55.75M
2023-12-31-$71.33M
2023-03-31-$72.37M
2022-12-31-$48.97M
2022-03-31-$25.85M
2021-12-31-$29.05M
2021-09-30-$14.1M
2021-06-30-$17.97M
2021-03-31-$18.48M
2020-12-31-$90.55M
2020-09-30-$5.35M
2020-06-30-$6.31M
2020-03-31-$7.93M
2019-12-31-$10M
2019-09-30-$11.13M
2019-06-30-$8.84M
2019-03-31-$11.66M
2018-12-31-$10.38M
2018-09-30-$9.05M
2018-06-30-$8.76M
2018-03-31-$4.55M
2017-12-31-$6.27M
2017-09-30-$5.79M
2017-06-30-$7.25M
2017-03-31-$6.87M
2016-12-31-$5.83M
2016-09-30-$3.98M
2016-06-30-$3.35M
2016-03-31-$3.46M
2015-12-31-$2.91M
2015-03-31-$2.57M
2014-12-31-$2.22M
2014-09-30-$1.6M
2014-06-30-$2.78M
2014-03-31-$131,000.00
2013-12-31$290,398.00
2013-09-30-$274,659.00
2013-06-30-$22,373.00

Annual EBITDA

DateEBITDA
2025-12-31-$362.94M
2024-12-31-$298.5M
2023-12-31-$253.93M
2022-12-31-$134.05M
2021-12-31-$79.61M
2020-12-31-$110.14M
2019-12-31-$41.69M
2018-12-31-$32.8M
2017-12-31-$26.22M
2016-12-31-$16.65M
2015-12-31-$11M
2014-12-31-$6.72M
2013-12-31-$49,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.